After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.
Stocks Info
IMNM belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. The current market capitalization of Immunome Inc is $786.72M. A total of 0.57 million shares were traded on the day, compared to an average of 610.34K shares.
In the most recent transaction, Rosett Max sold 14,380 shares of IMNM for 16.01 per share on Sep 19 ’24. After the transaction, the Chief Financial Officer now owns 47,476 company shares. In a previous transaction on Sep 19 ’24, Rosett Max bought 14,380 shares at 16.01 per share.
Among the insiders who bought shares, BIENAIME JEAN JACQUES acquired of 7,000 shares on Aug 16 ’24 at a per-share price of $13.94. This resulted in the Director holding 16,615 shares of IMNM after the transaction. In another insider transaction, Higgins Jack sold 3,524 shares at $13.93 per share on Aug 15 ’24. Company shares held by the Chief Scientific Officer now total 16,000.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, IMNM has a high of $30.96 and a low of $6.93.
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. IMNM’s latest balance sheet shows that the firm has $49.23M in Cash & Short Term Investments as of fiscal 2021. There were $317.00k in debt and $9.73M in liabilities at the time. Its Book Value Per Share was $4.23, while its Total Shareholder’s Equity was $48.19M.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for IMNM is Buy with a score of 5.00.
